Overview
Paul Hendrie is a Hematologist in Seattle, Washington. Dr. Hendrie is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Langerhans Cell Histiocytosis, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Aspiration. Dr. Hendrie is currently accepting new patients.
His clinical research consists of co-authoring 62 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Histiocytosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1701 Columbia Rd, Seattle, WA 98195
1570 N 115th St, Seattle, WA 98133
1550 N 115th St, Seattle, WA 98133
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Hirohisa Nakamae is a Hematologist in Seattle, Washington. Dr. Nakamae is rated as a Distinguished provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dennis Willerford is an Oncologist and a Hematologist Oncology provider in Poulsbo, Washington. Dr. Willerford is rated as a Distinguished provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Waldenstrom Macroglobulinemia, Adult Immune Thrombocytopenia, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Willerford is currently accepting new patients.
Franciscan Oncology At St. Joseph
"Joseph Rosales, MD, has been a physician for over 20 years and a hematologist-oncologist in Western Washington since 2011 -- in Seattle, Federal Way and Tacoma. He is experienced in general hematology and oncology, with specialties in breast and thoracic oncology. Dr. Rosales considers himself a guide in his patients’ therapeutic journey. He meets his patients wherever they are - physically and emotionally - and strives to provide them the knowledge and perspective required to navigate difficult decisions in their care. His treatment philosophy has been consistent: to make sure that the patient remains in as much control of their care as possible while getting the best care possible.Dr. Rosales also maintains activity within the community, including involvement in oncologic education and advocacy. He received the2022 Binaytara Foundation for Excellence in Cancer Care ""Rising Star in Health Equity"" awardfor his demonstration of excellent leadership in improving cancer care in underprivileged communities.Multidisciplinary Lung Cancer Treatment during Covid-19 Video". Dr. Rosales is rated as a Distinguished provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)Dr. Hendrie isElite. Learn about Acute Myeloid Leukemia (AML).
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Langerhans Cell HistiocytosisDr. Hendrie isDistinguished. Learn about Langerhans Cell Histiocytosis.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- AgranulocytosisDr. Hendrie isAdvanced. Learn about Agranulocytosis.
- Bloom SyndromeDr. Hendrie isAdvanced. Learn about Bloom Syndrome.
- Childhood Acute Myeloid LeukemiaDr. Hendrie isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Hendrie isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Myelomonocytic Leukemia (CMML)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Hendrie isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaDr. Hendrie isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Promyelocytic LeukemiaDr. Hendrie isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Hendrie isExperienced. Learn about Adult Immune Thrombocytopenia.
- Antiphospholipid SyndromeDr. Hendrie isExperienced. Learn about Antiphospholipid Syndrome.
- Aplastic AnemiaDr. Hendrie isExperienced. Learn about Aplastic Anemia.